|4Jun 16, 3:50 PM ET

Caplan Vered 4

4 · Orgenesis Inc. · Filed Jun 16, 2022

Insider Transaction Report

Form 4
Period: 2022-06-14
Caplan Vered
Director
Transactions
  • Award

    Stock Option

    2022-06-14+85,00085,000 total
    Exercise: $2.00Exp: 2032-06-14Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a two-year period, beginning on September 30, 2022.

Documents

1 file
  • 4
    ownership.xmlPrimary